China Isotope & Radiation (HKSE:01763) EV-to-EBIT : 2.14 (As of May. 11, 2024)

View and export this data going back to 2018. Start your Free Trial

What is China Isotope & Radiation EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, China Isotope & Radiation's Enterprise Value is HK$2,245 Mil. China Isotope & Radiation's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1,048 Mil. Therefore, China Isotope & Radiation's EV-to-EBIT for today is 2.14.

The historical rank and industry rank for China Isotope & Radiation's EV-to-EBIT or its related term are showing as below:

HKSE:01763' s EV-to-EBIT Range Over the Past 10 Years
Min: 1.96 Med: 5.36 Max: 13.31
Current: 2.15

During the past 9 years, the highest EV-to-EBIT of China Isotope & Radiation was 13.31. The lowest was 1.96. And the median was 5.36.

HKSE:01763's EV-to-EBIT is ranked better than
91.65% of 455 companies
in the Medical Devices & Instruments industry
Industry Median: 20.82 vs HKSE:01763: 2.15

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. China Isotope & Radiation's Enterprise Value for the quarter that ended in Dec. 2023 was HK$5,661 Mil. China Isotope & Radiation's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1,048 Mil. China Isotope & Radiation's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 18.52%.

China Isotope & Radiation EV-to-EBIT Historical Data

The historical data trend for China Isotope & Radiation's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Isotope & Radiation EV-to-EBIT Chart

China Isotope & Radiation Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

7.22

11.05

6.83

4.13

5.40

China Isotope & Radiation Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial											6.83	-	4.13	-	5.40

Competitive Comparison of China Isotope & Radiation's EV-to-EBIT

For the Medical Devices subindustry, China Isotope & Radiation's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Isotope & Radiation's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, China Isotope & Radiation's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where China Isotope & Radiation's EV-to-EBIT falls into.

China Isotope & Radiation EV-to-EBIT Calculation

China Isotope & Radiation's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	2244.802	/	1048.474
	=	2.14

China Isotope & Radiation's current Enterprise Value is HK$2,245 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Isotope & Radiation's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1,048 Mil.

China Isotope & Radiation (HKSE:01763) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

China Isotope & Radiation's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	1048.474	/	5660.967
	=	18.52 %

China Isotope & Radiation's Enterprise Value for the quarter that ended in Dec. 2023 was HK$5,661 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Isotope & Radiation's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1,048 Mil.

China Isotope & Radiation EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of China Isotope & Radiation's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

China Isotope & Radiation (HKSE:01763) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » China Isotope & Radiation Corp (HKSE:01763) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 66 Changwa Middle Street, Haidian District, Beijing, CHN, 100089

Website

https://www.china-isotope.com

China Isotope & Radiation Corp is a Chinese company. It has five operating segments: Pharmaceuticals; Radioactive source products; Irradiation; Radiation therapy equipment and related services and Other businesses. Its Pharmaceutical segment is the key revenue driver, which manufactures and sells imaging diagnostic and therapeutic radiopharmaceuticals imaging, UBT diagnostic kits, and test analyzers, and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The Group's operations are carried out and majority of the Group's customers are located in the PRC.

China Isotope & Radiation (HKSE:01763) Headlines

No Headlines